A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children

• Main Authors: Emilia García-Menor MD (Author), Fátima García-Marín MD (Author), Raquel Vecino-López MD, PhD (Author), Gloria Horcajo-Martínez MD (Author), María-José de Ibarrondo Gu (Author), Pedro Gómez-González MD (Author), Syra Velasco-Ortega Pharm (Author), Javier Suárez-Almarza Pharm, BSND (Author), Concepción Nieto-Magro MD, PhD (Author)
• Format: Book
• Published: SAGE Publishing, 2016-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This randomized, open-label study evaluated the additional benefits of the synbiotic Prodefen® in the clinical management of acute diarrhea of suspected viral origin in children between 6 months and 12 years of age. Study outcomes included the duration of diarrhea, the recovery from diarrhea, and th...